Importantly, we found that endogenous RNF144A interacted with endogenous PARP1 in human breast epithelial HBL100 cells and human breast cancer BT474 cells by IP analysis using an anti-PARP1 antibody (Figure 2B). This evidence concerns the gene PARP1 and breast carcinoma.